Insider Transactions in Q3 2022 at Chinook Therapeutics, Inc. (KDNY)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2022
|
Davis Jerel Director |
SELL
Other acquisition or disposition
|
Indirect |
974,918
-59.76%
|
-
|
|
Sep 12
2022
|
Davis Jerel Director |
BUY
Other acquisition or disposition
|
Indirect |
28,313
+47.07%
|
-
|
|
Sep 12
2022
|
Davis Jerel Director |
BUY
Other acquisition or disposition
|
Direct |
3,291
+0.22%
|
-
|
|
Sep 02
2022
|
Dolca Thomas Director |
BUY
Open market or private purchase
|
Direct |
10,000
+26.46%
|
$210,000
$21.21 P/Share
|
|
Aug 12
2022
|
Davis Jerel Director |
BUY
Other acquisition or disposition
|
Direct |
1,646
+0.22%
|
-
|
|
Aug 12
2022
|
Davis Jerel Director |
SELL
Other acquisition or disposition
|
Indirect |
482,768
-46.42%
|
-
|
|
Aug 12
2022
|
Davis Jerel Director |
BUY
Other acquisition or disposition
|
Indirect |
9,466
+44.13%
|
-
|
|
Aug 04
2022
|
Andrew James King Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-45.88%
|
$100,000
$20.0 P/Share
|
|
Aug 04
2022
|
Andrew James King Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+31.45%
|
$0
$0.35 P/Share
|
|
Jul 11
2022
|
Andrew James King Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-45.88%
|
$90,000
$18.09 P/Share
|
|
Jul 11
2022
|
Andrew James King Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+31.45%
|
$0
$0.35 P/Share
|